Navigating Your Weight Loss Journey: Can You Take Ozempic with Mounjaro?

Embarking on a weight loss journey often brings a landscape of choices, particularly as advancements in medical science offer powerful new tools. For many, managing weight or Type 2 diabetes involves understanding medications like Ozempic and Mounjaro, which have significantly reshaped how we approach these health challenges. A common, yet critical, question arises for individuals exploring these options: can you take Ozempic with Mounjaro? The simple answer to taking them simultaneously is generally no, but the journey of understanding why and how to navigate transitions between these impactful medications is far more nuanced.

At TrimRx, our journey began with a shared vision to help individuals embrace healthier lifestyles by merging cutting-edge telehealth innovations with effective weight loss solutions. We understand that each person’s path is unique, and we are dedicated to providing personalized, medically supported care. This article will delve into the distinct mechanisms of Ozempic and Mounjaro, explore why combining them is typically not recommended, and provide a comprehensive guide on safely transitioning between them under professional guidance. We believe that sustainable weight loss should be achieved through science, empathy, and a transparent approach, and we are here to support you every step of the way. By the end of this post, you’ll have a clearer understanding of these medications and how a personalized approach can empower your health goals.

Understanding GLP-1 and GIP Receptor Agonists: Ozempic and Mounjaro

The advent of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonists has marked a significant turning point in the management of Type 2 diabetes and chronic weight management. These medications harness the body’s natural systems to regulate blood sugar and influence appetite. To truly understand why the question “can you take Ozempic with Mounjaro” is so pertinent, we must first appreciate their individual roles and mechanisms.

Ozempic (Semaglutide): Mechanism and Uses

Ozempic, with its active ingredient semaglutide, is a well-established GLP-1 receptor agonist. It is administered as a once-weekly injection, offering a convenient and effective treatment option for many. Its primary mechanism involves mimicking the natural GLP-1 hormone produced in the gut. When food is consumed, GLP-1 is released, signaling the pancreas to increase insulin production when blood sugar levels are high. Simultaneously, it reduces the amount of glucose released by the liver and slows down gastric emptying. This trifecta of actions leads to improved blood sugar control.

Beyond its role in diabetes management, semaglutide has a profound impact on appetite and satiety. By slowing digestion and influencing hunger signals in the brain, it helps individuals feel fuller for longer, often leading to reduced caloric intake and significant weight loss. Ozempic is FDA-approved for managing Type 2 diabetes alongside diet and exercise. It is also approved to reduce the risk of major cardiovascular events in adults with Type 2 diabetes and established heart disease, and to reduce the risk of worsening kidney disease in adults with Type 2 diabetes and chronic kidney disease. While Ozempic itself is not FDA-approved for weight loss, its active ingredient, semaglutide, is available under the brand name Wegovy® for chronic weight management in eligible individuals. Many healthcare providers recognize its benefits for weight loss and may prescribe it off-label for this purpose when appropriate.

For those wondering about their suitability for such a medication, we encourage you to take our free assessment quiz to see if you qualify for our personalized prescription weight loss programs.

Mounjaro (Tirzepatide): Dual Action and Broader Impact

Mounjaro, containing the active ingredient tirzepatide, represents a newer generation of these medications, distinguishing itself through a dual-action mechanism. It acts as both a GIP and GLP-1 receptor agonist. This means Mounjaro not only mimics GLP-1, similar to Ozempic, but also simultaneously activates GIP receptors. GIP is another incretin hormone that plays a crucial role in glucose metabolism and energy balance.

The dual agonism of tirzepatide offers a potentially more potent effect on blood sugar regulation and weight management. By engaging both pathways, Mounjaro can lead to enhanced insulin secretion, suppressed glucagon release, slowed gastric emptying, and a more pronounced reduction in appetite. Mounjaro is FDA-approved for the management of Type 2 diabetes. Like Ozempic, it is also frequently used off-label for weight loss due to its significant efficacy in this area. Its active ingredient, tirzepatide, is also available under the brand name Zepbound® specifically for chronic weight management. Clinical trials have indicated that Mounjaro can lead to substantial reductions in A1C levels and greater weight loss percentages compared to single GLP-1 agonists.

Key Differences: Efficacy, Mechanism, and Side Effects

While both Ozempic and Mounjaro are once-weekly injectable medications that offer significant benefits for Type 2 diabetes and weight management, their distinct mechanisms lead to some key differences:

• Mechanism of Action: This is the most fundamental difference. Ozempic is a GLP-1 monotherapy, whereas Mounjaro is a dual GIP/GLP-1 agonist. Mounjaro’s dual action is believed to contribute to its potentially greater efficacy in both blood sugar control and weight reduction.
• Efficacy in Blood Sugar and Weight Loss: Research, such as the SURPASS-2 trial comparing tirzepatide and semaglutide, has shown that Mounjaro (tirzepatide) often achieves greater reductions in A1C levels and a higher percentage of total body weight loss compared to Ozempic (semaglutide). For example, studies suggest Mounjaro users may experience up to 20% total body weight reduction, while Ozempic users might see around 10-15%.
• Side Effect Profiles: Both medications share common gastrointestinal side effects, including nausea, vomiting, diarrhea, constipation, and abdominal pain. While individual experiences vary, some studies suggest that Mounjaro may have a slightly higher incidence or severity of certain gastrointestinal side effects, particularly at higher doses, due to its dual action. However, often these side effects lessen over time as the body adjusts. Both medications carry warnings for potential severe adverse events like pancreatitis, gallbladder issues, and a boxed warning for thyroid C-cell tumors.
• FDA Indications: Ozempic holds additional FDA approvals for reducing cardiovascular risk and kidney disease progression in Type 2 diabetes patients, which Mounjaro currently does not. However, the active ingredients (semaglutide as Wegovy® and tirzepatide as Zepbound®) are both FDA-approved for chronic weight management.

Understanding these differences is crucial when discussing treatment options with a healthcare provider. At TrimRx, we prioritize clear communication and personalized guidance. Our comprehensive service includes doctor consultations, medication (like compounded Semaglutide, Oral Semaglutide, Ozempic®, compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, Zepbound®, or Wegovy® depending on eligibility), lab work, unlimited support, and convenient shipping, all without hidden fees. We partner with licensed medical professionals to ensure you receive the safest and most effective care, tailored to your individual needs.

The Question of Combination Therapy: Can You Take Ozempic with Mounjaro?

Given the distinct benefits and mechanisms of Ozempic and Mounjaro, it’s natural to wonder if combining them could offer synergistic effects or enhanced outcomes. However, the unequivocal advice from healthcare professionals and regulatory bodies is generally clear: taking both Ozempic and Mounjaro simultaneously is not recommended.

Why Simultaneous Use is Not Recommended

The primary reason against combining these medications stems from their overlapping pharmacological mechanisms. Both Ozempic and Mounjaro act on the GLP-1 receptor, and Mounjaro additionally targets the GIP receptor. Introducing both drugs at once would lead to a phenomenon known as therapeutic duplication.

• Overlapping Mechanisms: While Mounjaro adds the GIP component, both drugs significantly engage the GLP-1 pathway. Administering both simultaneously would essentially mean “double-dosing” on the GLP-1 effect.
• Increased Risk of Side Effects: The most immediate and significant concern with combination therapy is a substantial increase in the likelihood and severity of adverse effects. As discussed, both medications commonly cause gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation. Combining them could exacerbate these symptoms, leading to severe discomfort, dehydration, and potentially more serious complications.
• Lack of Efficacy and Safety Data: There is no clinical research supporting the safety or enhanced efficacy of taking Ozempic and Mounjaro concurrently. Medical guidelines are based on rigorous trials that test medications individually or in approved combinations. Without such data, using them together ventures into unknown territory regarding patient safety and therapeutic benefit.
• Regulatory Guidance: Regulatory bodies and pharmaceutical manufacturers specifically advise against concurrent use. For example, product information for both drugs highlights their distinct roles and does not suggest combination therapy.

It’s vital to remember that these medications are potent tools designed to elicit specific physiological responses. Their careful titration and administration under medical supervision are paramount. Attempting to self-prescribe or combine medications without expert guidance can lead to dangerous health outcomes.

Therapeutic Duplication and Safety Concerns

Therapeutic duplication occurs when a patient is prescribed or takes more than one medication from the same drug category or therapeutic class to treat the same condition. In the case of Ozempic and Mounjaro, both fall under the category of incretin-based therapies. While Mounjaro is a dual agonist, its significant GLP-1 action makes its co-administration with another GLP-1 agonist like Ozempic a clear instance of therapeutic duplication.

The risks associated with therapeutic duplication extend beyond just intensified common side effects:

• Hypoglycemia Risk: While less common with GLP-1 agonists alone, the enhanced insulinotropic effect from combining them could potentially increase the risk of hypoglycemia (low blood sugar), especially when taken with other diabetes medications.
• Gastrointestinal Complications: Severe gastrointestinal distress could lead to issues like gastroparesis (delayed stomach emptying), bowel obstructions, or electrolyte imbalances requiring medical intervention.
• Unpredictable Drug Interactions: These medications can also affect the absorption of other oral medications by slowing gastric emptying. Combining them could lead to even more significant changes in the absorption rates of other vital drugs an individual may be taking, with unpredictable and potentially harmful consequences.
• Pancreatitis and Gallbladder Issues: Both medications carry warnings about pancreatitis and gallbladder disease. Combining them could theoretically increase the risk or severity of these serious conditions.

Therefore, the consensus among healthcare professionals is clear: Ozempic and Mounjaro should not be taken together. Instead, the focus should be on optimizing treatment with one medication, or, if necessary, safely transitioning from one to the other under expert medical guidance. If you’re exploring options, our free assessment quiz is a great first step to determine which personalized prescription program might be right for you.

Navigating the Switch: From Ozempic to Mounjaro, or Vice Versa

While taking Ozempic and Mounjaro simultaneously is not recommended, transitioning between them is a common practice that can be done safely and effectively with proper medical guidance. Healthcare providers often consider switching a patient from one medication to the other for various reasons, always with the goal of optimizing treatment outcomes.

Reasons for Considering a Switch

Several factors might prompt a healthcare provider and patient to consider switching from Ozempic to Mounjaro, or the reverse:

• Inadequate Efficacy: If blood sugar goals are not being met, or weight loss has plateaued or is insufficient on one medication, switching to the other, potentially more potent option (like Mounjaro for greater weight loss), might be considered.
• Side Effect Management: While both share similar side effects, an individual may tolerate one medication better than the other. If one experiences intolerable side effects with Ozempic, Mounjaro might be better tolerated, and vice versa.
• Specific Health Conditions: Ozempic has FDA approval for reducing cardiovascular events and kidney disease progression in Type 2 diabetes. If a patient develops or has a history of these conditions, and is not already on Ozempic, a switch might be clinically beneficial.
• Desire for Greater Weight Loss: Clinical data suggests Mounjaro may lead to a higher percentage of total body weight loss. For individuals whose primary goal includes more significant weight reduction, a switch to Mounjaro could be explored.
• Medication Availability and Coverage: Practical factors such as insurance coverage, medication cost (which we do not discuss here), or even drug shortages can influence the decision to switch, though clinical effectiveness and safety remain paramount.
• Allergic Reaction: In rare cases, an allergic reaction to one medication might necessitate a switch to an alternative.

At TrimRx, we emphasize that your journey is unique. Our platform facilitates connections with licensed healthcare professionals who take into account your individual medical history, current health status, and specific goals when determining the most appropriate and safe treatment path. We believe in compassionate care that respects every individual’s unique journey.

The Importance of Medical Supervision

Any decision to switch between these powerful medications must be made in close consultation with and under the direct supervision of a licensed healthcare provider. Self-switching or altering dosages can be dangerous and lead to adverse outcomes. Here’s why medical supervision is non-negotiable:

• Personalized Assessment: A doctor will thoroughly review your medical history, current health conditions, other medications, and previous responses to treatment. This comprehensive assessment is crucial for determining if a switch is appropriate and safe for you.
• Dose Adjustment and Titration: There is no official dose equivalence or simple conversion chart between Ozempic and Mounjaro due to their different mechanisms and dosing structures. Your provider will determine the appropriate starting dose of the new medication, usually beginning at a low dose, and will guide the titration schedule to minimize side effects and optimize efficacy.
• Monitoring for Side Effects: During the transition period, your healthcare provider will monitor you closely for any new or worsening side effects, particularly gastrointestinal issues or signs of low blood sugar.
• Blood Glucose Monitoring: Regular monitoring of blood glucose levels is essential to ensure that the new medication regimen effectively manages your diabetes and to make any necessary adjustments.
• Continuity of Care: A healthcare provider ensures a smooth, uninterrupted transition of care, preventing gaps in treatment that could impact your health.

TrimRx is committed to transparency and safety. We partner with licensed healthcare providers for consultations and prescription issuance, and work exclusively with FDA-registered and inspected pharmacies for the shipping of weight loss medications. This approach ensures that your treatment plan is not only effective but also delivered with the highest standards of safety and compliance. When you’re ready to explore your options, take our free assessment quiz to begin your personalized journey with a licensed medical professional.

Transitioning Safely: Dosing and Timing Considerations

When switching from Ozempic to Mounjaro, or vice versa, your healthcare provider will devise a specific plan tailored to your situation. This plan typically addresses the timing of the switch and the starting dose of the new medication.

From Mounjaro to Ozempic

If you are transitioning from Mounjaro to Ozempic, your provider might consider the following:

• Timing: If you were experiencing side effects from Mounjaro, your provider might advise waiting until those symptoms subside before starting Ozempic, as Mounjaro can remain in your system for several weeks. If side effects were minimal or absent, starting Ozempic approximately one week after your last Mounjaro dose (on the same day of the week) is a common approach.
• Starting Dose: The healthcare provider will likely start Ozempic at a low dose (e.g., 0.25 mg once weekly) and gradually increase it over several weeks, monitoring your response and any side effects. Even if you were on a higher dose of Mounjaro, direct equivalent dosing for Ozempic is not typically used.

From Ozempic to Mounjaro

Conversely, when switching from Ozempic to Mounjaro:

• Timing: Similar to the above, if you experienced side effects from Ozempic, your provider might wait a few weeks (Ozempic can stay in your system for about five weeks) before initiating Mounjaro to ensure symptoms have resolved. If tolerating Ozempic well, Mounjaro might be started approximately one week after your last Ozempic dose.
• Starting Dose: Mounjaro will typically be initiated at its lowest starting dose (e.g., 2.5 mg once weekly) and slowly titrated upwards. This gradual increase helps the body adjust to the new medication and mitigates potential side effects.

Your healthcare provider’s decision will be based on your current dose, the duration of treatment, your health goals, and how your body reacts to the medication. It’s not about finding a direct “conversion” but rather finding the optimal starting point and titration schedule for the new medication. This careful, individualized approach is a cornerstone of the compassionate care we support at TrimRx.

Managing Side Effects During a Transition

Experiencing side effects is a common aspect of starting or switching between GLP-1 and GIP receptor agonists. While most are mild and transient, particularly during dose escalation, awareness and proactive management are key.

• Gradual Dosing: The gradual dose escalation strategy employed by healthcare providers is specifically designed to minimize side effects, allowing your body time to adjust.
• Dietary Adjustments: Eating smaller, more frequent meals, avoiding high-fat or greasy foods, and consuming bland foods can help alleviate nausea and stomach discomfort. Staying well-hydrated is also crucial, especially if experiencing diarrhea or vomiting.
• Hydration and Fiber: For constipation, increasing fluid intake and consuming fiber-rich foods, or using over-the-counter laxatives as advised by your doctor, can be beneficial.
• Monitoring and Communication: Keep a detailed log of any side effects, their severity, and their timing. Regular communication with your healthcare provider is vital. They can offer strategies, adjust your dose, or provide additional support to manage these symptoms effectively.
• Beware of Hypoglycemia: While GLP-1s generally have a low risk of hypoglycemia when used alone, combining them with other diabetes medications can increase this risk. Be aware of the signs of low blood sugar (dizziness, confusion, rapid heart rate, shakiness) and report them immediately.

Remember, your well-being is our priority. Our personalized weight loss program, accessible through our free assessment quiz, offers unlimited support from our care team throughout your journey, ensuring you have the resources and guidance to manage any challenges.

TrimRx’s Personalized Approach to Weight Loss and Medication Management

At TrimRx, we understand that true wellness extends beyond just a number on the scale. It’s about empowering individuals with the tools, knowledge, and support they need to achieve sustainable health improvements. Our platform is a testament to our core values: empathy, innovation, trustworthiness, support, results-orientation, and personalization. We believe that every weight loss journey deserves a scientifically backed, compassionate, and transparent approach.

Our Vision and Values

Our journey at TrimRx began with a clear vision: to revolutionize weight loss by integrating cutting-edge telehealth innovations with clinically proven, effective solutions. We saw a need for a user-friendly and supportive space where individuals could receive personalized, medically supervised care designed to make sustainable weight loss attainable and tailored to their unique circumstances.

We stand firm in our belief that sustainable weight loss should be achieved through science, empathy, and a transparent approach. This means:

• Science-Backed Solutions: We offer access to medications like compounded Semaglutide, Oral Semaglutide, Ozempic®, compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, Zepbound®, and Wegovy®, all provided through FDA-registered, inspected, and approved pharmacies, ensuring you receive high-quality, effective treatments. It is important to note that while branded medications like Ozempic® and Zepbound® are FDA-approved, compounded medications are not. We simply partner with these FDA-registered and inspected pharmacies for dispensing.
• Empathetic Care: We recognize that weight loss is deeply personal and often challenging. Our approach is one of compassionate care, respecting every individual’s unique journey and providing understanding support.
• Transparency: Our commitment to transparent service means you always know what to expect. Our approach remains consistent, regardless of dosage changes, ensuring clarity and trust.

Medically Supervised Programs: How We Support Your Journey

TrimRx offers personalized weight loss programs that are built on the foundation of medically supported care. We connect you with licensed healthcare providers who conduct thorough consultations, review your medical history, and, if appropriate, prescribe medications that align with your health goals.

Our comprehensive service includes:

• Doctor Consultations: Access to licensed medical professionals for initial assessments and ongoing guidance.
• Lab Work: To ensure your safety and tailor your treatment, necessary lab work is included.
• Medication: If you qualify, your personalized plan may include prescription medications. Our medications are provided through FDA-registered, inspected, and approved pharmacies. We emphasize that branded medications like Ozempic® and Zepbound® are FDA-approved, while compounded medications are not. We partner with these pharmacies for the shipping of weight loss medications.
• Unlimited Support: Our dedicated care team is available to answer your questions, provide encouragement, and help you navigate your treatment plan.
• Shipping: Convenient delivery of your medication directly to your door.
• No Hidden Fees: Our transparent model ensures you understand the full scope of your program.

To see if you qualify for our personalized prescription weight loss programs, we invite you to take our free assessment quiz. This quiz is the first step towards receiving a tailored treatment plan designed for your success.

The Role of Our FDA-Registered Partner Pharmacies

Safety is paramount at TrimRx. We understand the importance of quality and reliability in medication delivery. That’s why we work exclusively with FDA-registered and inspected pharmacies. These partnerships ensure that all medications dispensed through our programs meet stringent quality and safety standards.

It is important to reiterate that while we facilitate access to medically supported care through licensed healthcare providers, TrimRx does not provide actual medical supervision ourselves. That crucial role is performed by the consulting doctors who evaluate your health and prescribe your treatment. Our role is to provide a platform and service that makes this medically supervised journey accessible and seamless, always ensuring that any prescription medications, whether compounded Semaglutide, Oral Semaglutide, Ozempic®, compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, Zepbound®, or Wegovy®, are sourced from reputable, compliant pharmacies.

Beyond Prescription: Holistic Support and Quick-Access Supplements

We recognize that a successful weight loss journey is often multifaceted, requiring more than just medication. Our brand ethos extends to supporting overall wellness, which is why we also offer quick-access supplements that do not require a quiz for purchase. These supplements are designed to complement your weight loss efforts and support your general well-being.

• GLP-1 Daily Support: This supplement is formulated to provide comprehensive daily support, complementing your body’s natural processes as you work towards your weight loss goals.
• Weight Loss Boost: Designed to give your weight loss efforts an extra edge, this supplement can be a valuable addition to your regimen, helping you feel more energized and focused.

These quick-access supplements are available for immediate purchase, providing convenient support for your overall wellness during your weight loss journey. They embody our commitment to providing a holistic range of solutions to meet you wherever you are on your path to a healthier lifestyle.

Making an Informed Decision for Your Health

The decision to embark on a weight loss journey, particularly one involving prescription medications, is significant. It requires careful consideration, open communication with healthcare professionals, and a commitment to personalized care. Understanding the nuances of medications like Ozempic and Mounjaro, including why you cannot take Ozempic with Mounjaro simultaneously, is a crucial part of this process.

By choosing a program that prioritizes safety, efficacy, and individualized support, you set yourself up for sustainable success. At TrimRx, we are dedicated to providing that supportive environment, connecting you with expert medical guidance, and offering a range of clinically proven solutions tailored to your needs. Whether you are exploring prescription options or seeking supplemental support, we are here to empower you every step of the way. Your journey to a healthier, more vibrant life is our shared mission.

Conclusion

The complexities of weight management and Type 2 diabetes often lead to questions about optimizing therapeutic strategies, including whether one can take Ozempic with Mounjaro. As we have explored, while both medications are powerful tools in their own right, designed to promote significant health improvements, they are not intended to be used concurrently due to overlapping mechanisms and the increased risk of adverse effects. The safest and most effective path involves a personalized approach, where a licensed healthcare provider guides the choice and management of your medication, including any necessary transitions.

We’ve delved into the distinct actions of Ozempic and Mounjaro, highlighting Mounjaro’s dual GIP/GLP-1 agonism and Ozempic’s established benefits for cardiovascular and kidney health. Understanding these differences, coupled with the critical importance of medical supervision during any medication switch, underpins a responsible and effective weight loss journey.

At TrimRx, we are proud to offer a platform that facilitates access to medically supported weight loss solutions, merging innovation with compassionate care. Our commitment to transparency, safety, and personalized support is unwavering. From the initial free assessment quiz that connects you with a licensed healthcare provider to the continuous support and high-quality medications sourced from FDA-registered pharmacies, we are here to ensure your journey is as smooth and successful as possible. For those seeking immediate support for overall wellness, our GLP-1 Daily Support and Weight Loss Boost supplements are readily available. Your health and well-being are at the heart of everything we do.

Frequently Asked Questions

Can I take Ozempic and Mounjaro together for better weight loss results?

No, taking Ozempic and Mounjaro together is not recommended. Both medications work on similar pathways in the body (specifically the GLP-1 receptor, with Mounjaro also targeting GIP), and combining them can lead to an increased risk of severe side effects such as nausea, vomiting, diarrhea, and other gastrointestinal issues. There is no clinical data to support the safety or enhanced efficacy of this combination. Your healthcare provider will guide you on the most appropriate single medication for your needs.

What are the main differences between Ozempic and Mounjaro?

Ozempic (semaglutide) is a GLP-1 receptor agonist, meaning it mimics the GLP-1 hormone to help regulate blood sugar, slow digestion, and reduce appetite. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, targeting both GLP-1 and GIP hormones. This dual action may lead to potentially greater reductions in A1C levels and higher percentages of weight loss compared to Ozempic in some individuals. Both are once-weekly injectable medications, but their specific FDA approvals and efficacy profiles differ slightly.

How do I switch from Ozempic to Mounjaro, or vice versa?

Switching between Ozempic and Mounjaro should only be done under the direct supervision of a licensed healthcare provider. They will evaluate your medical history, current dosage, and health goals to determine the safest and most effective transition plan. This typically involves starting the new medication at a low dose and gradually increasing it, while carefully monitoring for side effects. There is no direct dose conversion, so a personalized titration schedule is essential. If you’re considering a switch, take our free assessment quiz to discuss your options with a medical professional.

What support does TrimRx offer for individuals managing their weight loss medications?

TrimRx provides comprehensive, medically supported weight loss programs that include doctor consultations, lab work, prescription medications (like compounded Semaglutide, Oral Semaglutide, Ozempic®, compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, Zepbound®, or Wegovy®), unlimited support from our care team, and convenient shipping—all with no hidden fees. We partner with licensed healthcare providers for consultations and work with FDA-registered and inspected pharmacies for medication fulfillment. Additionally, we offer quick-access supplements like GLP-1 Daily Support and Weight Loss Boost to further support your wellness journey.